Sort by
Keyphrases
Health Benefits
100%
Economic Benefits
100%
Pneumatic Compression Device
100%
Phlebolymphedema
100%
Conservative Therapy
36%
Medical Resource Utilization
18%
Hospital Costs
18%
Inpatient Costs
18%
Minneapolis
9%
Cellulitis
9%
Private Health Insurance
9%
Case-control Analysis
9%
Occupational Therapy
9%
Hospitalization
9%
Therapeutic Intervention
9%
US Population
9%
Lymphedema
9%
Low Dose Rate
9%
Significant Benefit
9%
Economic Burden
9%
Administrative Claims Data
9%
Resource Cost
9%
Cost Rate
9%
Device-independent
9%
Matched Case-control
9%
Pneumatic Compression
9%
Insurance Claims
9%
Outpatient Physical Therapy
9%
Compression Therapy
9%
Health Intelligence
9%
Blue Health
9%
Chronic Venous Insufficiency
9%
Therapy Costs
9%
Outpatient Cost
9%
Flexitouch
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cellulitis
100%
Chronic Vein Insufficiency
100%
Lymphedema
100%
Medicine and Dentistry
Health Care Cost
100%
Outpatient
50%
Conservative Treatment
33%
Sequela
16%
Hospital Cost
16%
Lymphedema
8%
Cellulitis
8%
Physiotherapy
8%
Compression Therapy
8%
Chronic Venous Insufficiency
8%
Occupational Therapy
8%
Occupational Medicine
8%
Nursing and Health Professions
Compression Instrument
100%
Outpatient
54%
Conservative Treatment
36%
Hospital Cost
18%
Chronic Vein Insufficiency
9%
Physiotherapy
9%
Cellulitis
9%
Compression Therapy
9%
Lymphedema
9%
Occupational Therapy
9%